Press release
Estherian Launches Dedicated DHI Hair Transplant Clinic to Meet Growing Demand for Precision Hair Restoration
Istanbul, Turkey - Estherian, a medical aesthetics provider based in Istanbul, has announced the launch of its newly established DHI hair transplant clinic [https://estherian.com/dhi-transplant/], focusing exclusively on Direct Hair Implantation (DHI) procedures. The move comes in response to increased patient interest in minimally invasive, high-precision hair restoration methods.Image: https://www.abnewswire.com/upload/2025/05/3f1325b3acbd2adca6afb42f2cc847e0.jpg
The clinic is equipped with specialized infrastructure and a dedicated medical team trained in the DHI technique, which involves the direct implantation of hair follicles using a proprietary implanter tool. Unlike traditional hair transplant methods, DHI allows for greater control over angle, depth, and direction during implantation-a factor that contributes to more natural-looking outcomes and efficient graft survival.
The new unit is designed to streamline the clinical process from consultation to recovery, enabling shorter procedure times and improved post-operative recovery conditions. By centralizing DHI-specific tools and expertise, Estherian aims to improve both the technical consistency and patient experience associated with the method.
Image: https://www.abnewswire.com/upload/2025/05/0e78469f409246f124a02d8aa874294d.jpg
Responding to Global Hair Loss Trends
Global demand for surgical hair restoration continues to rise, driven by an increasing awareness of advanced techniques and a broadening demographic base of patients. The DHI method has gained traction for its ability to reduce handling time of grafts and minimize trauma to the scalp, which can translate to faster healing and higher follicle survival rates.
Estherian's clinic provides consultations, diagnosis, and follow-up care as part of an integrated treatment approach. All procedures are conducted in compliance with international safety protocols, and the clinic operates under the oversight of board-certified practitioners.
Istanbul's Role in Medical Tourism
Located in Istanbul, a city that has become a hub for medical tourism, the new DHI facility is part of a wider effort by Estherian to serve patients seeking access to advanced medical treatments at internationally accredited standards. The clinic offers multilingual support and facilitates end-to-end patient care, from travel coordination to post-procedure guidance.
A Step Forward in Clinical Specialization
While Estherian continues to offer a broad range of dermatological and aesthetic services, the establishment of a focused DHI hair transplant clinic marks a strategic shift toward clinical specialization.
The facility is now open to both local and international patients, with treatment bookings available through the company's official website: https://estherian.com
About Estherian Clinic
Established in 2020 by Dr. Cengizhan Ekizceli, Estherian Clinic is a private, multi-specialty medical center located in Istanbul, Turkey. The clinic offers a range of services, including hair transplantation, plastic surgery, dental treatments, and obesity surgery. With a focus on personalized care and adherence to international health standards, Estherian Clinic serves a diverse patient base from Europe, the USA, Canada, and Australia. The clinic provides comprehensive packages that encompass transportation, accommodation, medical tests, and translation services, aiming to deliver a seamless experience for medical tourists.
Media Contact
Company Name: Estherian Clinic
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=estherian-launches-dedicated-dhi-hair-transplant-clinic-to-meet-growing-demand-for-precision-hair-restoration]
Country: Turkey
Website: https://estherian.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Estherian Launches Dedicated DHI Hair Transplant Clinic to Meet Growing Demand for Precision Hair Restoration here
News-ID: 4039043 • Views: …
More Releases from ABNewswire

Service Auto Glass Expands Mobile Auto Glass Repair and Replacement Across Phoen …
Mesa, AZ - 3 September, 2025 - Service Auto Glass [https://www.serviceautoglassaz.com/], a trusted name in the auto glass industry since 1997, is setting new standards in mobile auto glass repair and auto glass replacement throughout the Phoenix Metro, Mesa, Gilbert, and East Valley regions. Founded by Matt Crook, a veteran with over three decades of industry expertise, the company delivers fast, convenient, and reliable solutions for everything from windshield replacement…

Myotonic Dystrophy Market to Experience Notable Growth in Forecast Span by 2034, …
The Key Myotonic Dystrophy Companies in the market include - Design Therapeutics, Enzerna, Juvena Therapeutics, Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma, Lupin, AMO Pharma, Dyne Therapeutics, Entrada Therapeutics, and others.
DelveInsight's "Myotonic Dystrophy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myotonic Dystrophy, historical and forecasted epidemiology as well as the Myotonic Dystrophy market trends in the United States, EU5 (Germany, Spain, Italy, France,…

Vascular Dementia Market Insights Highlight Expanding Outlook Till 2034, DelveIn …
The Key Vascular Dementia Companies in the market include - Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP Pharma, Johnson & Johnson, Materia Medica Holding, Eisai Co., Ltd., Shineway Pharma, Merz Pharma, Ever Neuro Pharma GmbH, Zhejiang Otsuka Pharma, Janssen, LP, GE Healthcare, and others.
DelveInsight's "Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as…

Sow Crazy: New Wildflower Seed Brand Launched to Support UK Pollinators and Urba …
A new independent brand, Sow Crazy [https://sowcrazy.co.uk], has officially launched with a mission to help more people create wildlife-friendly gardens across the UK.
Sow Crazy specialises in curated wildflower seed mixes designed to encourage biodiversity in gardens, allotments, and community spaces. With urban green spaces under pressure, and widespread concern over declining bee and butterfly populations, the launch comes at a timely moment for gardeners seeking practical ways to support local…
More Releases for Estherian
Estherian Turkey Emerges as a Global Leader in Medical Tourism with $4.5 Billion …
The global medical tourism industry is experiencing unprecedented growth, with market valuations jumping from $4.5 billion in 2022 to a projected $43.7 billion by 2030-representing a staggering 32.9% CAGR. At the center of this boom sits Turkey, quietly capturing significant market share through a combination of cost efficiency, advanced technology, and strategic positioning.
The Numbers Behind The Growth
Recent market analysis reveals that medical tourists can save 60-70% on procedures compared to…